Madrigal Pharmaceuticals Inc
MDGL
$449.74-2.19%
End of day · as of Oct 16, 2026, 4:15 PM ET
Mkt cap
$11.56B
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$958.40M
EPS (TTM)
$-12.87
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-30.08%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Latest reported MDGL revenue for 2025-12-31 was $958.4M. Net income was -$288.3M. Revenue was up 432.1% from 2024-12-31 to 2025-12-31. MDGL currently screens at market cap $11.56B.
Use this MDGL research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MDGL income, balance, and cash tables.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company in the Healthcare sector.
Latest cached Madrigal Pharmaceuticals Inc (MDGL) revenue for Dec 31, 2025 was $958.4M. Net income was -$288.3M. Statements: https://lician.com/financials/mdgl
Madrigal Pharmaceuticals Inc (MDGL) market capitalization is $11.56B on the latest cached snapshot.
Madrigal Pharmaceuticals Inc (MDGL) cached previous close $459.81; day range $449.74 – $459.57; volume 361,172. Session quote: https://lician.com/quote/mdgl
Madrigal Pharmaceuticals Inc (MDGL) latest cached earnings event is "MDGL earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached MDGL filing is 8-K · Aug 12, 2026. Filings: https://lician.com/sec/mdgl